89
Views
11
CrossRef citations to date
0
Altmetric
Review

Idiopathic generalized epilepsies: clinical and electroencephalogram diagnosis and treatment

, &
Pages 753-767 | Published online: 10 Jan 2014

References

  • Anonymous. Randomized clinical trial on the efficacy of anti-epileptic drugs in reducing the risk of relapse after a first unprovoked tonic- clonic seizure. First Seizure Trial Group (FIR.S.T. Group). Neurology 43(3 Pt 1), 478–483 (1993).
  • King MA, Newton MR, Jackson GD, Berkovic SF. Epileptology of the first-seizure presentation: a clinical, electroencephalographic, and magnetic imaging study of 300 consecutive patients. Lancet 352, 1007–1011 (1998).
  • Hirtz D, Ashwal S, Berg A et al. Practice parameter: evaluating a first nonfebrile seizure in children: report of the quality standards subcommittee of the American Academy of Neurology, The Child Neurology Society, and The American Epilepsy Society. Neurology 55(5), 616–623 (2000).
  • Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30, 389–399 (1989).
  • Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22(4), 489–501 (1981).
  • Gibbs FA, Davis H, Lennox WG. The electroencephalogram in epilepsy and in conditions of impaired consciousness. Arch. Neurol. Psychiatry 34, 1133–1148 (1935).
  • Gibbs FA, Gibbs EL, Lennox WG. Epilepsy: a paroxysmal cortical dysrhythmia. Brain 60, 377–388 (1937).
  • Penfield W, Jasper HH. Epilepsy and the Functional Anatomy of the Human Brain. Little, Brown & Co., Boston, MA, USA (1954).
  • Gloor P. Generalized cortico-reticular epilepsies. Some considerations on the pathophysiology of generalized bilaterally synchronous spike and wave discharge. Epilepsia 9(3), 249–263 (1968).
  • Chauvel P, Kliemann F, Vignal JP, Chodkiewicz JP, Talairach J, Bancaud J. The clinical signs and symptoms of frontal lobe seizures. Phenomenology and classification. Adv. Neurol. 66, 115–125 (1995).
  • Marcus EM, Watson CW, Simon SA. An experimental model of some varieties of petit mal epilepsy. Electrical–behavioral correlations of acute bilateral epileptogenic foci in cerebral cortex. Epilepsia 9(3), 233–248 (1968).
  • Avoli M, Kostopoulos G. Participation of corticothalamic cells in penicillin-induced generalized spike and wave discharges. Brain Res. 247(1), 159–163 (1982).
  • Aliberti V, Grunewald RA, Panayiotopoulos CP, Chroni E. Focal electroencephalographic abnormalities in juvenile myoclonic epilepsy. Epilepsia 35(2), 297–301 (1994).
  • Lombroso CT. Consistent EEG focalities detected in subjects with primary generalized epilepsies monitored for two decades. Epilepsia 38(7), 797–812 (1997).
  • Lancman ME, Asconape JJ, Golimstok A. Circling seizures in a case of juvenile myoclonic epilepsy. Epilepsia 35(2), 317–318 (1994).
  • Lancman ME, Asconape JJ, Penry JK. Clinical and EEG asymmetries in juvenile myoclonic epilepsy. Epilepsia 35(2), 302–306 (1994).
  • Aguglia U, Gambardella A, Le Piane E et al. Idiopathic generalized epilepsies with versive or circling seizures. Acta Neurol. Scand. 99(4), 219–224 (1999).
  • Kiley MA, Smith SJ, Sander JW. Idiopathic generalized epilepsy presenting with hemiconvulsive seizures. Epilepsia 41(12), 1633–1636 (2000).
  • So EL, King DW, Murvin AJ. Misdiagnosis of complex absence seizures. Arch. Neurol. 41(6), 640–641 (1984).
  • Engel J Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy, Report of the ILAE Task Force on Classification and Terminology. Epilepsia 42, 796–803 (2001).
  • Delgado-Escueta AV, Greenberg D, Weissbecker K et al. Gene mapping in the idiopathic generalized epilepsies: juvenile myoclonic epilepsy, childhood absence epilepsy, epilepsy with grand mal seizures, and early childhood myoclonic epilepsy. Epilepsia 31(Suppl. 3), S19–S29 (1990).
  • Penry JK, Porter RJ, Dreifuss RE. Simultaneous recording of absence seizures with video tape and electroencephalography. A study of 374 seizures in 48 patients. Brain 98(3), 427–440 (1975).
  • Stefan H, Burr W, Hinderbrand D, Penin H. Basic temporal structure of absence symptoms. In: Advances in Epileptology: The 13th Epilepsy International Symposium. Kazamatsuri H, Seino M, Ward AA (Eds). Raven Press, NY, USA, 55–60 (1982).
  • Panayiotopoulos CP, Obeid T, Waheed G. Differentiation of typical absence seizures in epileptic syndromes. A video EEG study of 224 seizures in 20 patients. Brain 112(Pt. 4), 1039–1056 (1989).
  • Agathonikou A, Panayiotopoulos CP, Giannakodimos S, Koutroumanidis M. Typical absence status in adults: diagnostic and syndromic considerations. Epilepsia 39(12), 1265–1276 (1998).
  • Koutroumanidis M. Absence status. Epilepsy Disorders (2005) (In Press).
  • Walker M, Cross H, Smith S et al. Nonconvulsive status epilepticus: Epilepsy Research Foundation Workshop Reports. Epileptic Disord. 7(3), 253–296 (2005).
  • Panayiotopoulos CP, Chroni E, Daskalopoulos C, Baker A, Rowlinson S, Walsh P. Typical absence seizures in adults: clinical, EEG, video-EEG findings and diagnostic/syndromic considerations. J. Neurol. Neurosurg. Psychiatr. 55(11), 1002–1008 (1992).
  • Panayiotopoulos CP, Koutroumanidis M, Giannakodimos S, Agathonikou A. Idiopathic generalised epilepsy in adults manifested by phantom absences, generalised tonic-clonic seizures, and frequent absence status. J. Neurol. Neurosurg. Psychiatr. 63(5), 622–627 (1997).
  • Michelucci R, Rubboli G, Passarelli D et al. Electroclinical features of idiopathic generalised epilepsy with persisting absences in adult life. J. Neurol. Neurosurg. Psychiatry 61(5), 471–477 (1996).
  • Marini C, King MA, Archer JS, Newton MR, Berkovic SF. Idiopathic generalised epilepsy of adult onset: clinical syndromes and genetics. J. Neurol. Neurosurg. Psychiatry 74(2), 192–196 (2003).
  • Panayiotopoulos CP. Idiopathic generalised epilepsies. In: The Epilepsies: Seizures, Syndromes and Management. Panayiotopoulos CP (Ed.). Bladon Medical Publishing, Oxford, UK, 271–348 (2005).
  • North KN, Ouvrier RA, Nugent M. Pseudoseizures caused by hyperventilation resembling absence epilepsy. J. Child Neurol. 5(4), 288–294 (1990).
  • Tukel K, Jasper H. The electroencephalogram in parasagittal lesions. Electroencephalogr. Clin. Neurophysiol. 4(Suppl. 4), 481–494 (1952).
  • Blume WT, Pillay N. Electrographic and clinical correlates of secondary bilateral synchrony. Epilepsia 26(6), 636–641 (1985).
  • Bancaud J, Talairach J. Clinical semiology of frontal lobe seizures. Adv. Neurol. 57, 3–58 (1992).
  • Raymond AA, Fish DR, Sisodiya SM, Alsanjari N, Stevens JM, Shorvon SD. Abnormalities of gyration, heterotopias, tuberous sclerosis, focal cortical dysplasia, microdysgenesis, dysembryoplastic neuroepithelial tumour and dysgenesis of the archicortex in epilepsy. Clinical,EEG and neuroimaging features in 100 adult patients. Brain 118, 629–660 (1995).
  • Li LM, Donoghue MF, Smith SJM. Outcome of epilepsy surgery in patients with temporal lobe epilepsy associated with 3–4Hz generalised spike and wave discharges. J. Epilepsy 9, 210–214 (1996).
  • Koutroumanidis M, Hennessy MJ, Elwes RD, Binnie CD, Polkey CE. Coexistence of temporal lobe and idiopathic generalized epilepsies. Neurology 53(3), 490–495 (1999).
  • Nicolson A, Chadwick DW, Smith DF. The coexistence of idiopathic generalized epilepsy and partial epilepsy. Epilepsia 45(6), 682–685 (2004).
  • Luders H, Acharya J, Baumgartner C et al. Semiological seizure classification. Epilepsia 39(9), 1006–1013 (1998).
  • Agathonikou A, Giannakodimos S, Ahmed Sharoqi I, Koutroumanidis M, Sanders S, Panayiotopoulos CP. Typical absences in adults: a clinico-EEG study of 93 patients. Epilepsia 38(Suppl. 3), 225 (1997).
  • Fountain NB, Kim JS, Lee SI. Sleep deprivation activates epileptiform discharges independent of the activating effects of sleep. J. Clin. Neurophysiol. 15(1), 69–75 (1998).
  • Halasz P, Filakovszky J, Vargha A, Bagdy G. Effect of sleep deprivation on spike–wave discharges in idiopathic generalised epilepsy: a 4 x 24 h continuous long-term EEG monitoring study. Epilepsy Res. 51(1–2), 123–132 (2002).
  • Lee SI, Kirby D. Absence seizure with generalized rhythmic delta activity. Epilepsia 29(3), 262–267 (1988).
  • Epstein MA, Duchowny M, Jayakar P. Altered responsivenessduring hyperventilation-induced EEG slowing: a non-epileptic phenomenon in normal children. Epilepsia 35, 1204–1207 (1994).
  • Engel GL, Ferris EB, Logan M. Hyperventilation: analysis of clinical symptomatology. Ann. Intern. Med. 27, 683–704 (1947).
  • Lum LM, Connolly MB, Farrell K, Wong PK. Hyperventilation-induced high-amplitude rhythmic slowing with altered consciousness: a video-EEG comparison with absence seizures. Epilepsia 43(11), 1372–1378 (2002).
  • Andermann F, Keene DL, Andermann E, Quesney LF. Startle disease or hyperekplexia: further delineation of the syndrome. Brain 103(4), 985–997 (1980).
  • Gastaut H, Broughton R. A clinical and polygraphic study of episodic phenomena during sleep. Recent Adv. Biol. Psychiatry 7, 197–221 (1965).
  • Broughton R, Tolentino MA, Krelina M. Excessive fragmentary myoclonus in NREM sleep: a report of 38 cases. Electroencephalogr. Clin. Neurophysiol. 61(2), 123–133 (1985).
  • Koutroumanidis M, Hennessy MJ, Chandler C. Postoperative myoclonus simulating seizure recurrence: a rare complication of anterior temporal lobectomy. Br. J. Neurosurg. 15(2), 174–177 (2001).
  • Lombroso CT, Fejerman N. Benign myoclonus of early infancy. Ann. Neurol. 1(2), 138–143 (1977).
  • Farrell K. Classifying epileptic syndromes: problems and a neurobiologic solution. Neurology 43(11 Suppl. 5), S8–S11 (1993).
  • Covanis A, Skiadas K, Loli N, Lada C, Theodorou V. Absence epilepsy: early prognostic signs. Seizure 1(4), 281–289 (1992).
  • Wirrell E, Camfield C, Camfield P, Dooley J. Prognostic significance of failure of the initial anti-epileptic drug in children with absence epilepsy. Epilepsia 42(6), 760–763 (2001).
  • Covanis A, Skiadas K, Loli N, Lada C, Theodorou V. Absence epilepsy: early prognostic signs. Seizure 1(4), 281–289 (1992).
  • Koutroumanidis M, Smith SJ. Use and abuse of EEG in the diagnosis of idiopathic generalised epilepsies. Epilepsia (2005) (In Press).
  • Jeavons PM, Clark JE, Maheshwari MC. Treatment of generalized epilepsies of childhood and adolescence with sodium valproate (‘epilim’). Dev. Med. Child Neurol. 19(1), 9–25 (1977).
  • Villarreal HJ, Wilder BJ, Willmore LJ et al. Effect of valproic acid on spike and wave discharges in patients with absence seizures. Neurology 28(9 Pt. 1), 886–891 (1978).
  • Covanis A, Gupta AK, Jeavons PM. Sodium valproate: monotherapy and polytherapy. Epilepsia 23(6), 693–720 (1982).
  • Berkovic SF, Andermann F, Guberman A, Hipola D, Bladin PF. Valproate prevents the recurrence of absence status. Neurology 39(10), 1294–1297 (1989).
  • Verrotti A, Greco R, Chiarelli F, Domizio S, Sabatino G, Morgese G. Epilepsy with myoclonic absences with early onset: a follow-up study. J. Child Neurol. 14(11), 746–749 (1999).
  • Richens A. Ethosuximide and valproate. In: Typical Absences and Related Epileptic Syndromes. Duncan JS, Panayiotopoulos CP (Eds). Churchill Comunications Europe, London, UK, 361–367 (1995).
  • Callaghan N, O’Hare J, O’Driscoll D, O’Neill B, Daly M. Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal). Dev. Med. Child Neurol. 24(6), 830–836 (1982).
  • Sato S, White BG, Penry JK et al. Valproic acid versus ethosuximide in the treatment of absence seizures. Neurology 32(2), 157–163 (1982).
  • Buoni S, Grosso S, Fois A. Lamotrigine in typical absence epilepsy. Brain Dev. 21(5), 303–306 (1999).
  • Frank LM, Enlow T, Holmes GL et al. Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia 40(7), 973–979 (1999).
  • Gericke CA, Picard F, Saint-Martin A, Strumia S, Marescaux C, Hirsch E. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study. Epileptic Disord. 1(3), 159–165 (1999).
  • Barron TF, Hunt SL, Hoban TF, Price ML. Lamotrigine monotherapy in children. Pediatr. Neurol. 23(2), 160–163 (2000).
  • Culy CR, Goa KL. Lamotrigine. A review of its use in childhood epilepsy. Paediatr. Drugs 2(4), 299–330 (2000).
  • Biraben A, Allain H, Scarabin JM, Schuck S, Edan G. Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurology 55(11), 1758 (2000).
  • Laegreid L, Kyllerman M, Hedner T, Hagberg B, Viggedahl G. Benzodiazepine amplification of valproate teratogenic effects in children of mothers with absence epilepsy. Neuropediatrics 24(2), 88–92 (1993).
  • Ferrie CD, Robinson RO, Knott C, Panayiotopoulos CP. Lamotrigine as an add-on drug in typical absence seizures. Acta Neurol. Scand. 91(3), 200–202 (1995).
  • Panayiotopoulos CP, Ferrie CD, Knott C, Robinson RO. Interaction of lamotrigine with sodium valproate [letter]. Lancet 341(8842), 445 (1993).
  • Beran RG, Berkovic SF, Dunagan FM et al. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy. Epilepsia 39(12), 1329–1333 (1998).
  • Manonmani V, Wallace SJ. Epilepsy with myoclonic absences. Arch. Dis. Child. 70(4), 288–290 (1994).
  • Rowan AJ, Meijer JW, de Beer-Pawlikowski N, van der Geest P, Meinardi, H. Valproate-ethosuximide combination therapy for refractory absence seizures. Arch. Neurol. 40(13), 797–802 (1983).
  • Tassinari CA, Michelucci R, Rubboli G et al. Myoclonic absence epilepsy. In: Typical Absences and Related Epileptic Syndromes. Duncan JS, Panayiotopoulos CP (Eds). Churchill Communications Europe, London, UK, 187–195 (1995).
  • Mattson RH, Cramer JA. Valproic acid and ethosuximide interaction. Ann. Neurol. 7(6), 583–584 (1980).
  • Mikkelsen B, Birket-Smith E, Bradt S et al. Clonazepam in the treatment of epilepsy. A controlled clinical trial in simple absences, bilateral massive epileptic myoclonus, and atonic seizures. Arch. Neurol. 33(5), 322–325 (1976).
  • Martin D, Hirt HR. Clinical experience with clonazepam (Rivotril) in the treatment of epilepsies in infancy and childhood. Neuropediatr. 4, 245–266 (1973).
  • Naito H, Wachi M, Nishida M. Clinical effects and plasma concentrations of long-term clonazepam monotherapy in previously untreated epileptics. Acta Neurol. Scand. 76(1), 58–63 (1987).
  • Obeid T, Panayiotopoulos CP. Clonazepam in juvenile myoclonic epilepsy. Epilepsia 30(5), 603–606 (1989).
  • Nanda RN, Johnson RH, Keogh HJ, Lambie DG, Melville ID. Treatment of epilepsy with clonazepam and its effect on other anticonvulsants. J. Neurol. Neurosurg. Psychiatry 40(6), 538–543 (1977).
  • Ames FR, Enderstein O. Clinical and EEG response to clonazepam in four patients with self-induced photosensitive epilepsy. S. Afr. Med. J. 50(3F), 1432–1434 (1976).
  • Browne TR. Clonazepam. N. Engl. J. Med. 299(15), 812–816 (1978).
  • Lombroso CT, Forsythe I. Long-term follow-up of acetazolamide (Diamox) in the treatment of epilepsy. Epilepsia 1, 493–500 (1969).
  • Chiao DH, Plumb RL. Diamox in epilepsy. A review of 178 cases. J. Pediatr. 58, 211–218 (1961).
  • Resor SR Jr, Resor LD. Chronic acetazolamide monotherapy in the treatment of juvenile myoclonic epilepsy. Neurology 40(11), 1677–1681 (1990).
  • Montouris G, Biton V, Rosenfeld W, the Topiramate YTC/YTCE study group. Nonfocal generalized tonic-clonic seizures: response during long-trem topiramate treatment. Epilepsia 41(Suppl. 1), S77–S81 (2000).
  • Wheless JW. Use of topiramate in childhood generalized seizure disorders. J. Child. Neurol. 15(Suppl. 1), S7–S13 (2000).
  • Nieto BM. Characteristics and indications of topiramate. Rev. Neurol. 35(Suppl. 1), S88–S95 (2002).
  • Prasad A, Knowlton RC, Mendez M, Martin R, Kuzniecky R, Faught E. A comparison of lamotrigine and topiramate in juvenile myoclonic epilepsy. Epilepsia 43(Suppl. 7), 198–199 (2002).
  • Prasad A, Kuzniecky RI, Knowlton RC et al. Evolving anti-epileptic drug treatment in juvenile myoclonic epilepsy. Arch. Neurol. 60(8), 1100–1105 (2003).
  • Greenhill L, Betts T, Smith K. Effect of levetiracetam on resistant juvenile myoclonic epilepsy. Epilepsia 43(Suppl. 7), 179 (2002).
  • Resor SR, Resor LD. Levetiracetam monotherapy in the treatment of convulsive seizures in juvenile myoclonic epilepsy. American Academy Neurology, 54th Annual Meeting, April (2002).
  • Jongsma M, Janssen G, Engelsman M, Haan D. Promising results of levetiracetam in juvenile myoclonic epilepsy. Epilepsia 43(Suppl. 8), 153 (2002).
  • Czapinski PP, Czapinska EM. The effectiveness of levetiracetam in drug-resistant juvenile myoclonic epilepsy. Epilepsia 45(Suppl. 3), 141 (2004).
  • La Neve A, Boero G, Specchio N et al. Levetiracetam is effective in juvenile myoclonic epilepsy. Epilepsia 45(Suppl.3), 141 (2004).
  • Kasteleijn-Nolst Trenite DG, Marescaux C, Stodieck S, Edelbroek PM, Oosting J. Photosensitive epilepsy: a model to study the effects of anti-epileptic drugs. Evaluation of the piracetam analogue, levetiracetam. Epilepsy Res. 25(3), 225–230 (1996).
  • Wheless JW, Sankar R. Treatment strategies for myoclonic seizures and epilepsy syndromes with myoclonic seizures. Epilepsia 44(Suppl. 11), 27–37 (2003).
  • Lerman-Sagie T, Watemberg N, Kramer U, Shahar E, Lerman P. Absence seizures aggravated by valproic acid. Epilepsia 42(7), 941–943 (2001).
  • Callahan DJ, Noetzel MJ. Prolonged absence status epilepticus associated with carbamazepine therapy, increased intracranial pressure, and transient MRI abnormalities. Neurology 42(11), 2198–2201 (1992).
  • Snead OC III, Hosey LC. Exacerbation of seizures in children by carbamazepine. N. Engl. J. Med. 313(15), 916–921 (1985).
  • Liporace JD, Sperling MR, Dichter MA. Absence seizures and carbamazepine in adults. Epilepsia 35(5), 1026–1028 (1994).
  • Gelisse P, Genton P, Kuate D, Pesenti A, Baldy-Moulinier M, Crespel A. Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies. Epilepsia 45(10), 1282–1288 (2004).
  • Panayiotopoulos CP. Typical absence seizures and their treatment. Arch. Dis. Child. 81, 351–355 (1999).
  • Schapel G, Chadwick D. Tiagabine and non-convulsive status epilepticus. Seizure 5(2), 153–156 (1996).
  • Eckardt KM, Steinhoff BJ. Nonconvulsive status epilepticus in two patients receiving tiagabine treatment. Epilepsia 39(6), 671–674 (1998).
  • Genton P. When anti-epileptic drugs aggravate epilepsy. Brain Dev. 22(2), 75–80 (2000).
  • Osorio I, Reed RC, Peltzer JN. Refractory idiopathic absence status epilepticus: a probable paradoxical effect of phenytoin and carbamazepine. Epilepsia 41(7), 887–894 (2000).
  • D’Agostino MD, Andermann F, Dubeau F, Fedi M, Bastos A. Exceptionally long absence status: multifactorial etiology, drug interactions and complications. Epileptic Disord. 1(4), 229–232 (1999).
  • Callenbach PM, Geerts AT, Arts WF et al. Familial occurrence of epilepsy in children with newly diagnosed multiple seizures: Dutch Study of Epilepsy in Childhood. Epilepsia 39(3), 331–336 (1998).
  • Berg AT, Levy SR, Testa FM, Shinnar S. Classification of childhood epilepsy syndromes in newly diagnosed epilepsy: interrater agreement and reasons for disagreement. Epilepsia 40(4), 439–444 (1999).
  • Loiseau P, Duche B, Pedespan JM. Absence epilepsies. Epilepsia 36(12), 1182–1186 (1995).
  • Oller L. Prospective study of the differences between the syndromes of infantile absence epilepsy and syndromes of juvenile absence epilepsy. Rev. Neurol. 24(132), 930–936 (1996).
  • Hirsch E, Marescaux C. What are the relevant criteria for a better classification of epileptic syndromes with typical absences? In: Idiopathic Generalised Epilepsies. Malafosse A, Genton P, Hirsch E, Marescaux C, Broglin D, Bernasconi R (Eds). John Libbey & Company Ltd, London, UK, 87–93 (1994).
  • Loiseau P, Duche B. Childhood absence epilepsy. In: Typical Absences and Related Epileptic Syndromes. Duncan JS, Panayiotopoulos CP (Eds). Churchill Communications Europe, London, UK, 152–160 (1995).
  • Cobb WA, Gordon N, Matthews SC, Nieman EA. The occipital delta rhythm in petit mal. Electroencephalogr. Clin. Neurophysiol. 13, 142–143 (1961).
  • Bureau M, Guey J, Dravet C, Roger J. Etude de la répartition des absences chez l’enfant en fonction de ses activités. Rev. Neurol. 118, 493–494 (1968).
  • Henriksen O, Johannessen SI. Clinical and pharmacokinetic observations on sodium valproate – a 5-year follow-up study in 100 children with epilepsy. Acta Neurol. Scand. 65(5), 504–523 (1982).
  • Bourgeois B, Beaumanoir A, Blajev B et al. Monotherapy with valproate in primary generalized epilepsies. Epilepsia 28(Suppl. 2), S8–S11 (1987).
  • Martinovic Z. Comparison of ethosuximide with sodium valproate. In: Advances in Epileptology. XIV Epilepsy International Symposium. Parsonage M, Grant RHE, Craig AG, Ward AA (Eds). Raven Press, NY, USA, 301–305 (1983).
  • Coppola G, Licciardi F, Sciscio N, Russo F, Carotenuto M, Pascotto A. Lamotrigine as first-line drug in childhood absence epilepsy: a clinical and neurophysiological study. Brain Dev. 26(1), 26–29 (2004).
  • Buchanan N. The use of lamotrigine in juvenile myoclonic epilepsy. Seizure 5(2), 149–151 (1996).
  • Fattouch J, Di Bonaventura C, Mari F et al. Role of levetiracetam in the treatment of primary generalised epilepsy. Epilepsia 45(Suppl. 3), 142 (2004).
  • Panayiotopoulos CP, Ferrie CD, Koutroumanidis M, Rowlinson S, Sanders S. Idiopathic generalised epilepsy with phantom absences and absence status in a child. Epileptic Disord. 3(2), 63–66 (2001).
  • Panayiotopoulos CP, Obeid T, Waheed G. Absences in juvenile myoclonic epilepsy: a clinical and video-electroencephalographic study. Ann. Neurol. 25(4), 391–397 (1989).
  • Panayiotopoulos CP, Obeid T, Tahan AR. Juvenile myoclonic epilepsy: a 5-year prospective study. Epilepsia 35(2), 285–296 (1994).
  • Serratosa JM, Delgado-Escueta AV, Medina MT, Zhang Q, Iranmanesh R, Sparkes RS. Clinical and genetic analysis of a large pedigree with juvenile myoclonic epilepsy. Ann. Neurol. 39(2), 187–195 (1996).
  • Grunewald RA, Panayiotopoulos CP. Juvenile myoclonic epilepsy. A review. Arch. Neurol. 50(6), 594–598 (1993).
  • Gilliam F, Steinhoff BJ, Bittermann HJ, Kuzniecky R, Faught E, Abou-Khalil B. Adult myoclonic epilepsy: a distinct syndrome of idiopathic generalized epilepsy. Neurology 55(7), 1030–1033 (2000).
  • Wilkins AJ, Zifkin B, Andermann F, McGovern E. Seizures induced by thinking. Ann. Neurol. 11(6), 608–612 (1982).
  • Goossens LA, Andermann F, Andermann E, Remillard GM. Reflex seizures induced by calculation, card or board games, and spatial tasks: a review of 25 patients and delineation of the epileptic syndrome. Neurology 40(8), 1171–1176 (1990).
  • Ramani V. Reading epilepsy. Adv. Neurol. 75, 241–262 (1998).
  • Radhakrishnan K, Silbert PL, Klass DW. Reading epilepsy. An appraisal of 20 patients diagnosed at the Mayo Clinic, Rochester, Minnesota, between 1949 and 1989, and delineation of the epileptic syndrome. Brain 118( Pt 1), 75–89 (1995).
  • Koutroumanidis M, Koepp MJ, Richardson MP et al. The variants of reading epilepsy. A clinical and video-EEG study of 17 patients with reading-induced seizures. Brain 121(Pt. 8), 1409–1427 (1998).
  • Wolf P, Inoue Y. Complex reflex epilepsies: reading epilepsy and praxis induction. In: Epileptic Syndromes in Infancy, Childhood and Adolescence. Roger J, Bureau M, Dravet C, Genton P, Tassinari AC, Wolf P (Eds). John Libbey & Co. Ltd, Eastleigh, UK, 315–325 (2004).
  • Gelisse P, Genton P, Thomas P, Rey M, Samuelian JC, Dravet C. Clinical factors of drug resistance in juvenile myoclonic epilepsy. J. Neurol. Neurosurg. Psychiatry 70(2), 240–243 (2001).
  • Cohen J. Levetiracetam monotherapy for primary generalised epilepsy. Seizure 12(3), 150–153 (2003).
  • Covanis A, Katsalouli M. Levetiracetam monotherapy in generalised epilepsy and photosensitivity. Epilepsia 44(Suppl. 8), 80 (2003).
  • Gelisse P, Crespel A, Genton P, Baldy-Moulinier M. Dramatic effect of levetiracetam on epileptic negative myoclonus. Acta Neurol. Scand. 107(4), 302–303 (2003).
  • Kasteleijn-Nolst Trenite DG, Hirsch E. Levetiracetam: preliminary efficacy in generalized seizures. Epileptic Disord. 5(Suppl. 1), S39–S44 (2003).
  • Krauss GL, Betts T, Abou-Khalil B, Bergey G, Yarrow H, Miller A. Levetiracetam treatment of idiopathic generalised epilepsy. Seizure 12(8), 617–620 (2003).
  • Gallagher MJ, Eisenman LN, Brown KM et al. Levetiracetam reduces spike–wave density and duration during continuous EEG monitoring in patients with idiopathic generalized epilepsy. Epilepsia 45(1), 90–91 (2004).
  • Isojarvi JI, Rattya J, Myllyla VV et al. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Ann. Neurol. 43(4), 446–451 (1998).
  • Wallace SJ. Myoclonus and epilepsy in childhood: a review of treatment with valproate, ethosuximide, lamotrigine and zonisamide. Epilepsy Res. 29(2), 147–154 (1998).
  • Lin Y, Itomi K, Takada H et al. Benign myoclonic epilepsy in infants: video-EEG features and long-term follow-up. Neuropediatrics 29(5), 268–271 (1998).
  • Dravet C, Bureau M. Benign myoclonic epilepsy in infancy. In: Epileptic Syndromes in Infancy, Childhood and Adolescence (Third Edition). Roger J, Bureau M, Dravet C, Genton P, Tassinari CA, Wolf P (Eds). John Libbey & Co. Ltd, London, UK, 69–79 (2002).
  • Guerrini R, Parmeggiani A, Kaminska A, Dulac O. Myoclonic astatic epilepsy. In: Epileptic Syndromes in Infancy, Childhood and Adolescence. Third Edition. Roger J, Bureau M, Dravet C, Genton P, Tassinari CA, Wolf P (Eds). John Libbey & Co. Ltd, London, UK, 105–112 (2002).
  • Kaminska A, Ickowicz A, Plouin P, Bru MF, Dellatolas G, Dulac O. Delineation of cryptogenic Lennox-Gastaut syndrome and myoclonic astatic epilepsy using multiple correspondence analysis. Epilepsy Res. 36(1), 15–29 (1999).
  • Dulac O, Kaminska A. Use of lamotrigine in Lennox-Gastaut and related epilepsy syndromes. J. Child. Neurol. 12(Suppl. 1), S23–S28 (1997).
  • Jayawant S, Libretto SE. Topiramate in the treatment of myoclonic-astatic epilepsy in children: a retrospective hospital audit. J. Postgrad. Med. 49(3), 202–206 (2003).
  • Jeavons PM. Nosological problems of myoclonic epilepsies of childhood and adolescence. Dev. Med. Child Neurol. 19, 3–8 (1977).
  • Appleton RE, Panayiotopoulos CP, Acomb BA, Beirne M. Eyelid myoclonia with typical absences: an epilepsy syndrome. J. Neurol. Neurosurg. Psychiatr. 56(12), 1312–1316 (1993).
  • Giannakodimos S, Panayiotopoulos CP. Eyelid myoclonia with absences in adults: a clinical and video-EEG study. Epilepsia 37(1), 36–44 (1996).
  • Panayiotopoulos CP, Ferrie CD, Giannakodimos S, Robinson RO. Perioral myoclonia with absences: a new syndrome. In: Epileptic Seizures and Syndromes. Wolf P (Ed.). John Libbey & Company Ltd, London, UK, 143–153 (1994).
  • Bureau M, Tassinari AC. The syndrome of myoclonic absences. In: Epileptic Syndromes in Infancy, Childhood and Adolescence (Third Edition). Roger J, Bureau M, Dravet C, Genton P, Tassinari AC, Wolf P (Eds). John Libbey & Co. Ltd, Eastleigh, UK, 305–312 (2002).
  • Janz D. ‘Aufwach’-epilepsien (als ausdruckeinerden ‘nacht’-oder ‘schlaf’-epilepsien gegenuberzustellenden verlaufsform epileptischer erkrankungen). Arch. Z. Neurol. 73–98 (1953).
  • Janz D. The grand mal epilepsies and the sleeping-waking cycle. Epilepsia 3, 69–109 (1962).
  • Christian W. Bioelectrical characteristics of daily periodic forms of the course of epileptic diseases. Dtsch. Z. Nervenheilkd. 181, 413–444 (1960).
  • Christian W. The sleeping-waking period in sleeping-waking epilepsy. Nervenarzt 32, 266–275 (1961).
  • Hitiris N, Brodie MJ. Evidence-based treatment of idiopathic generalized epilepsies with older anti-epileptic drugs. Epilepsia (2005) (In Press).
  • Trevathan E. Epilepsy syndrome-specific anti-epileptic drug therapy for children. Lancet 356(9242), 1623–1624 (2000).
  • Koutroumanidis M. Treatment of epilepsies associated with typical absences. Expert Rev. Neurotherapeutics 2(3), 391–402 (2002).
  • Duncan JS. Anti-epileptic drugs and the electroencephalogram. Epilepsia 28(3), 259–266 (1987).
  • Appleton RE, Beirne M. Absence epilepsy in children: the role of EEG in monitoring response to treatment. Seizure 5(2), 147–148 (1996).
  • Klass DW. Electroencephalographic manifestations of complex partial seizures. Adv. Neurol. 11, 113–140 (1975).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.